Bausch Health Companies (BHC) Free Cash Flow (2009 - 2026)
Bausch Health Companies' (BHC) quarterly Free Cash Flow came in at $121.0 million in Q1 2026, up 26.04% year-on-year from $96.0 million in Q1 2025, and down 69.98% quarter-over-quarter from $403.0 million in Q4 2025.
Bausch Health Companies (BHC) Free Cash Flow (2009 - 2026) Analysis & Trends
Bausch Health Companies has disclosed Free Cash Flow across 18 years of filings, most recently posting $121.0 million for Q1 2026.
- Free Cash Flow for Q1 2026 came in at $121.0 million, up 26.04% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.0 billion (down 16.22% YoY), and the FY2025 annual result was $1.0 billion, down 20.4% from the prior year.
- Free Cash Flow came in at $121.0 million for Q1 2026 at Bausch Health Companies, down from $403.0 million in the prior quarter.
- In the past five years, Free Cash Flow ranged from a high of $495.0 million in Q4 2024 to a low of -$1.3 billion in Q3 2022.
- The 5-year median for Free Cash Flow is $190.0 million (2025), against an average of $132.6 million.
- Peak annual rise in Free Cash Flow reached 857.41% in 2022, while the deepest fall reached 362.87% in 2022.
- Bausch Health Companies' Free Cash Flow stood at $409.0 million in 2022, then decreased by 28.61% to $292.0 million in 2023, then surged by 69.52% to $495.0 million in 2024, then retreated by 18.59% to $403.0 million in 2025, then sank by 69.98% to $121.0 million in 2026.
- The last three Free Cash Flow figures came in at $121.0 million (Q1 2026), $403.0 million (Q4 2025), and $314.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | -208.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 291.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 362.50 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 136.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | -38.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -169.83 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 80.53 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 123.09 Mn |
| 10 | Bausch Health Companies | 1.93 Bn | 1.59 Bn | 2.48 Bn | 121.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 121.00 Mn |
| Mar 31, 2026 | 121.00 Mn |
| Dec 31, 2025 | 403.00 Mn |
| Dec 31, 2025 | 403.00 Mn |
| Sep 30, 2025 | 314.00 Mn |
| Sep 30, 2025 | 314.00 Mn |
| Jun 30, 2025 | 190.00 Mn |
| Jun 30, 2025 | 190.00 Mn |
| Mar 31, 2025 | 96.00 Mn |
| Mar 31, 2025 | 96.00 Mn |
| Dec 31, 2024 | 495.00 Mn |
| Dec 31, 2024 | 495.00 Mn |
| Sep 30, 2024 | 334.00 Mn |
| Sep 30, 2024 | 334.00 Mn |
| Jun 30, 2024 | 302.00 Mn |
| Jun 30, 2024 | 302.00 Mn |
| Mar 31, 2024 | 129.00 Mn |
| Mar 31, 2024 | 129.00 Mn |
| Dec 31, 2023 | 292.00 Mn |
| Dec 31, 2023 | 292.00 Mn |